News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
253,660 Results
Type
Article (10257)
Company Profile (17)
Press Release (243383)
Multimedia
Podcasts (27)
Webinars (2)
Section
Business (62992)
Career Advice (937)
Deals (13409)
Drug Delivery (27)
Drug Development (29638)
Employer Resources (30)
FDA (8042)
Job Trends (4880)
News (119132)
Policy (15721)
Tag
2027 Pharm Country Standard (2)
Academia (753)
Accelerated approval (36)
Adcomms (24)
Allergies (84)
Alliances (18057)
ALS (107)
Alzheimer's disease (705)
Antibody-drug conjugate (ADC) (236)
Approvals (8221)
Artificial intelligence (324)
Autoimmune disease (126)
Automation (32)
Bankruptcy (96)
Best Places to Work (4323)
Biosimilars (79)
Biotechnology (24)
Bladder cancer (98)
Brain cancer (38)
Breast cancer (357)
Cancer (2736)
Cardiovascular disease (194)
Career advice (754)
Career pathing (10)
CAR-T (144)
CDC (10)
Celiac Disease (1)
Cell therapy (413)
Cervical cancer (19)
Clinical research (26539)
Collaboration (915)
Company closure (3)
Compensation (867)
Complete response letters (88)
COVID-19 (920)
CRISPR (59)
C-suite (381)
Cystic fibrosis (62)
Data (3631)
Denatured (5)
Depression (82)
Dermatology (49)
Diabetes (206)
Diagnostics (2876)
Digital health (22)
Diversity (3)
Diversity, equity & inclusion (7)
Drug discovery (134)
Drug pricing (23)
Drug shortages (2)
Duchenne muscular dystrophy (138)
Earnings (31920)
Editorial (9)
Employer branding (3)
Employer resources (26)
Events (29612)
Executive appointments (353)
FDA (10431)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (6)
Frontotemporal dementia (19)
Funding (692)
Gene editing (137)
Generative AI (32)
Gene therapy (333)
GLP-1 (333)
Government (1426)
Grass and pollen (2)
Guidances (242)
Healthcare (5700)
HIV (39)
Huntington's disease (30)
IgA nephropathy (53)
Immunology and inflammation (105)
Immuno-oncology (46)
Indications (109)
Infectious disease (1062)
Inflammatory bowel disease (102)
Inflation Reduction Act (1)
Influenza (54)
Intellectual property (215)
Interviews (209)
IPO (7204)
IRA (6)
Job creations (693)
Job search strategy (581)
JPM (21)
Kidney cancer (6)
Labor market (37)
Layoffs (139)
Leadership (7)
Legal (2123)
Liver cancer (47)
Longevity (16)
Lung cancer (368)
Lymphoma (205)
Machine learning (28)
Management (7)
Manufacturing (425)
MASH (104)
Medical device (5399)
Medtech (5457)
Mergers & acquisitions (6951)
Metabolic disorders (506)
mRNA (83)
Multiple sclerosis (105)
NASH (7)
Neurodegenerative disease (193)
Neuropsychiatric disorders (41)
Neuroscience (1402)
NextGen: Class of 2026 (1758)
Non-profit (737)
Now hiring (12)
Obesity (189)
Opinion (85)
Ovarian cancer (75)
Pain (118)
Pancreatic cancer (144)
Parkinson's disease (134)
Partnered (19)
Patents (445)
Patient recruitment (266)
Peanut (33)
People (15023)
Pharmaceutical (4)
Pharmacy benefit managers (3)
Phase 1 (7610)
Phase 2 (10670)
Phase 3 (10938)
Pipeline (5053)
Policy (83)
Postmarket research (534)
Preclinical (3443)
Press Release (44)
Prostate cancer (145)
Psychedelics (29)
Radiopharmaceuticals (168)
Rare diseases (603)
Real estate (1231)
Recruiting (16)
Regulatory (15438)
Reports (29)
Research institute (636)
Resumes & cover letters (244)
Rett syndrome (30)
RNA editing (13)
RSV (23)
Schizophrenia (77)
Series A (108)
Series B (67)
Service/supplier (2)
Sickle cell disease (37)
Special edition (12)
Spinal muscular atrophy (82)
Sponsored (18)
Startups (995)
State (1)
Stomach cancer (6)
Supply chain (43)
Tariffs (12)
The Weekly (21)
Vaccines (362)
Venture capital (29)
Weight loss (101)
Women's health (33)
Worklife (2)
Date
Today (57)
Last 7 days (308)
Last 30 days (1545)
Last 365 days (13606)
2026 (6356)
2025 (13520)
2024 (15389)
2023 (17418)
2022 (23682)
2021 (23500)
2020 (20857)
2019 (15778)
2018 (11508)
2017 (12118)
2016 (10376)
2015 (12252)
2014 (8552)
2013 (7358)
2012 (8136)
2011 (8586)
2010 (7573)
Location
Africa (189)
Alabama (65)
Alaska (1)
Arizona (69)
Arkansas (3)
Asia (16310)
Australia (2888)
California (5645)
Canada (2535)
China (757)
Colorado (252)
Connecticut (331)
Delaware (183)
Europe (35043)
Florida (986)
Georgia (270)
Hawaii (3)
Idaho (16)
Illinois (405)
India (38)
Indiana (297)
Iowa (15)
Japan (264)
Kansas (65)
Kentucky (11)
Louisiana (9)
Maine (38)
Maryland (591)
Massachusetts (3883)
Michigan (160)
Minnesota (266)
Mississippi (2)
Missouri (43)
Montana (8)
Nebraska (7)
Nevada (41)
New Hampshire (34)
New Jersey (1543)
New Mexico (19)
New York (1729)
North Carolina (667)
North Dakota (7)
Northern California (2821)
Ohio (148)
Oklahoma (2)
Oregon (3)
Pennsylvania (1241)
Puerto Rico (13)
Rhode Island (21)
South America (348)
South Carolina (16)
Southern California (2284)
Tennessee (62)
Texas (1000)
United States (20434)
Utah (214)
Vermont (1)
Virginia (116)
Washington D.C. (18)
Washington State (450)
West Virginia (2)
Wisconsin (67)
Wyoming (1)
253,660 Results for "ion beam applications iba".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
IBA – ACQUISITION OF OWN SHARES - June 1, 2026
June 2, 2026
·
2 min read
Press Releases
IBA – TRANSPARENCY NOTIFICATION - May 5, 2026
May 5, 2026
·
2 min read
Press Releases
IBA – ACQUISITION OF OWN SHARES - May 19, 2026
May 19, 2026
·
2 min read
Drug Development
Beam one-ups Wave as both show promise of genetic editing for AATD
While both Beam Therapeutics and Wave Life Sciences touted notable biomarker benefits for their respective alpha-1 antitrypsin deficiency assets, analysts said that Beam might have the efficacy advantage as Wave’s drug hits an efficacy “ceiling.”
May 20, 2026
·
2 min read
·
Tristan Manalac
Press Releases
IBA launches Cyclone® iKure, a cyclotron designed for industrial scale Astatine-211 production
June 1, 2026
·
3 min read
Press Releases
IBA – ACQUISITION OF OWN SHARES - May 5, 2026
May 5, 2026
·
2 min read
Rare diseases
Beam’s Base Editor Advances to Pivotal Development on Back of ‘Impressive’ AATD Data
Beam is now in the strongest position of all companies advancing a genetic therapy for alpha-1 antitrypsin deficiency, according to analysts at William Blair.
March 26, 2026
·
1 min read
·
Tristan Manalac
Press Releases
IBA Introduces myQA StarTrack³ for Fast, High Resolution Linac QA with a Single Detector Setup
May 6, 2026
·
3 min read
Press Releases
IBA introduces AdaPTinsight XR, the next generation of CBCT imaging for image-guided proton therapy
May 13, 2026
·
3 min read
Press Releases
IBA launches Rhodotron® LITE, a new low‑power X‑ray accelerator expanding access to sustainable irradiation solutions
May 20, 2026
·
3 min read
1 of 25,366
Next
